Hydrochloric Acid

Hydrochloric Acid

SCHEMBL828797

Cl.Cl.[Ir].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 4/20 0.60
ESR2 known ✓ Q92731 4/20 0.60
GAA known ✓ P10253 1/20 0.46
DRD1 known ✓ P21728 2/20 0.34
CA2 known ✓ P00918 2/20 0.32
GLA known ✓ P06280 1/20 0.32
ACHE known ✓ P22303 1/20 0.32
HTR2A known ✓ P28223 1/20 0.30
TDP1 Q9NUW8 3/20 0.86
CYP3A4 P08684 1/20 0.86
KDM4E B2RXH2 1/20 0.46
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 3/20 0.35
TSHR P16473 4/20 0.32
CA1 P00915 2/20 0.32
CA9 Q16790 2/20 0.32
LMNA P02545 2/20 0.32
CA12 O43570 1/20 0.32
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10601609 1.00 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL10604144 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL8372285 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
Benzene SCHEMBL11521546 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL1584554 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL447754 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL9414432 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL7930992 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL288029 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL288031 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11597910-B2 Medical instrument, cell culture method, fluorine-containing cyclic olefin polymer and fluorine-containing cyclic olefin polymer composition for it, and cultured cells MITSUI CHEMICALS, INC. (JP) 2023-03-07 US disclosed
US-10035889-B2 Optical film MITSUI CHEMICALS, INC. (JP) 2018-07-31 US disclosed
US-20180086864-A1 MEDICAL INSTRUMENT, FLUORINE-CONTAINING CYCLIC OLEFIN POLYMER, FLUORINE-CONTAINING CYCLIC OLEFIN POLYMER COMPOSITION, AND CELL CULTURE METHOD MITSUI CHEMICALS, INC. (JP) 2018-03-29 US disclosed
EP-3279308-A1 MEDICAL INSTRUMENT, FLUORINATED CYCLIC OLEFIN POLYMER, FLUORINATED CYCLIC OLEFIN POLYMER COMPOSITION, AND CELL CULTURE METHOD Mitsui Chemicals, Inc. (JP) 2018-02-07 EP disclosed
US-20170233696-A1 MEDICAL INSTRUMENT, CELL CULTURE METHOD, FLUORINE-CONTAINING CYCLIC OLEFIN POLYMER AND FLUORINE-CONTAINING CYCLIC OLEFIN POLYMER COMPOSITION FOR IT, AND CULTURED CELLLS MITSUI CHEMICALS, INC. (JP) 2017-08-17 US disclosed
EP-3181681-A1 MEDICAL DEVICE, METHOD FOR CULTURING CELLS, FLUORINE-CONTAINING CYCLIC OLEFIN POLYMER, FLUORINE-CONTAINING CYCLIC OLEFIN POLYMER COMPOSITION, AND CULTURED CELLS Mitsui Chemicals, Inc. (JP) 2017-06-21 EP disclosed
US-20160032063-A1 Optical Film KEIO UNIVERSITY (JP) 2016-02-04 US disclosed
US-8143429-B2 Process for producing organic transition metal complex compound, metathesis catalyst produced by using the same, ring-opening metathesis polymer obtainable with the metathesis catalyst, and process for producing the polymer MITSUI CHEMICALS, INC. (JP) 2012-03-27 US disclosed
EP-1538173-B1 Hydrogenated ring-opening metathesis polymer and process for producing the same MITSUI CHEMICALS INC (JP) 2009-11-04 EP disclosed
EP-1275676-B1 HYDROGENATED RING-OPENING METATHESIS COPOLYMER AND PROCESS FOR PRODUCING THE SAME MITSUI CHEMICALS INC (JP) 2008-05-07 EP disclosed
US-7081501-B2 Hydrogenated ring-opening metathesis polymer and process for producing the same MITSUI CHEMICALS, INC. (JP) 2006-07-25 US disclosed
EP-1538173-A1 Hydrogenated ring-opening metathesis polymer and process for producing the same Mitsui Chemicals, Inc. (JP) 2005-06-08 EP disclosed
US-20050119412-A1 Hydrogenated ring-opening metathesis polymer and process for producing the same MITSUI CHEMICALS, INC. (JP) 2005-06-02 US disclosed
US-6800720-B2 BASE POLYMER CONTAINING AN ESTER GROUP TO BE DECOMPOSED TO A CARBOXYLIC ACID TO BECOME SOLUBLE IN THE DEVELOPER FOR A PHOTORESIST USED IN FINE WORKING OF A SEMICONDUCTOR USING ULTRAVIOLET RAY; HEAT RESISTANCE; OPTICS; ADHESION MITSUI CHEMICALS, INC. (JP) 2004-10-05 US disclosed
EP-1275676-A1 HYDROGENATED RING-OPENING METATHESIS COPOLYMER AND PROCESS FOR PRODUCING THE SAME Mitsui Chemicals, Inc. (JP) 2003-01-15 EP disclosed
US-20020165328-A1 Hydrogenated ring-opening metathesis copolymer and process for producing the same MITSUI CHEMICALS, INC. (JP) 2002-11-07 US disclosed
US-6372854-B1 POLYALKENAMERS USED AS PHOTORESISTS HAVING EXCELLENT OPTICAL ELECTRICAL PROPERTIES; HIGH RIGIDITY; HEAT RESISTANCE; ADHESION AND WEAR RESISTANCE; HYDROGENATION; ACIDOLYSIS MITSUI CHEMICALS, INC. (JP) 2002-04-16 US disclosed